Sept 12 (Reuters) - Novogen Ltd NRT.AX
* U.S. FDA approves investigational new drug application for Cantrixil(TM)(TRX-E-002-1) in ovarian cancer Source text for Eikon: Further company coverage: NRT.AX
Sept 12 (Reuters) - Novogen Ltd NRT.AX
* U.S. FDA approves investigational new drug application for Cantrixil(TM)(TRX-E-002-1) in ovarian cancer Source text for Eikon: Further company coverage: NRT.AX